A detailed history of Wellington Management Group LLP transactions in Exelixis, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 245,342 shares of EXEL stock, worth $8.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
245,342
Previous 369,879 33.67%
Holding current value
$8.74 Million
Previous $8.31 Million 23.4%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$21.96 - $27.6 $2.73 Million - $3.44 Million
-124,537 Reduced 33.67%
245,342 $6.37 Million
Q2 2024

Aug 13, 2024

BUY
$20.34 - $23.73 $1.54 Million - $1.8 Million
75,941 Added 25.84%
369,879 $8.31 Million
Q1 2024

May 15, 2024

BUY
$20.17 - $23.93 $5.93 Million - $7.03 Million
293,938 New
293,938 $6.98 Million
Q4 2023

Feb 12, 2024

BUY
$19.25 - $24.13 $2.5 Million - $3.14 Million
129,935 New
129,935 $3.12 Million
Q3 2023

Nov 14, 2023

SELL
$19.04 - $22.74 $75,227 - $89,845
-3,951 Reduced 3.66%
103,886 $2.27 Million
Q2 2023

Aug 14, 2023

BUY
$18.17 - $20.48 $364,344 - $410,664
20,052 Added 22.84%
107,837 $2.06 Million
Q1 2023

May 12, 2023

BUY
$16.3 - $19.41 $290,025 - $345,362
17,793 Added 25.42%
87,785 $1.7 Million
Q4 2022

Feb 13, 2023

BUY
$14.96 - $17.39 $624,714 - $726,189
41,759 Added 147.91%
69,992 $1.12 Million
Q3 2022

Nov 14, 2022

BUY
$15.68 - $22.27 $442,693 - $628,748
28,233 New
28,233 $442,000
Q4 2021

Feb 11, 2022

SELL
$15.84 - $21.88 $375,756 - $519,037
-23,722 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$16.3 - $21.14 $386,668 - $501,483
23,722 New
23,722 $502,000
Q4 2020

Feb 12, 2021

SELL
$18.39 - $24.8 $2.28 Million - $3.08 Million
-124,120 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$20.67 - $26.94 $2.57 Million - $3.34 Million
124,120 New
124,120 $3.04 Million
Q1 2020

May 14, 2020

SELL
$14.46 - $21.8 $743,186 - $1.12 Million
-51,396 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$15.15 - $18.89 $778,649 - $970,870
51,396 New
51,396 $906,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.5B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.